Bonafide Vaginal Moisturizer for Dryness Relief Revaree – 5 mg Hyaluronic Acid – Hormone-Free, Estrogen-Free – For Mild to Moderate Vaginal Dryness & Everyday Comfort — 2-Month Supply

Bonafide Vaginal Moisturizer for Dryness Relief Revaree – 5 mg Hyaluronic Acid – Hormone-Free, Estrogen-Free – For Mild to Moderate Vaginal Dryness & Everyday Comfort — 2-Month Supply

• #1 GYNECOLOGIST RECOMMENDED NON-PRESCRIPTION HYALURONIC ACID SUPPOSITORIES FOR VAGINAL DRYNESS: Revaree is a deeply hydrating vaginal moisturizer that relieves dryness due to estrogen decline in as little as nine days.[1] Simply use the comfortable, applicator-free insert once every three nights (or as recommended by your doctor).
• NO HORMONES & NO HARMFUL SIDE EFFECTS: Results of 4 head-to-head clinical trials show that the FDA-cleared formula in Revaree is as effective at relieving dryness as topical estrogen[1-4]—minus the hormones and other ingredients known to cause harmful side effects.
• CLINICALLY STUDIED SOLUTIONS: 84% of women experienced an improvement in vaginal dryness, 86% of women experienced a reduction in vaginal itching and burning,[1] and 96% of women plan to continue to use Revaree.[5]
• WORKS WITH YOUR BODY, NOT AGAINST IT: Formulated with hyaluronic acid (and without hormones), Revaree restores your body’s natural moisture all day, every day, for sustained comfort.
• LIFE-CHANGING RELIEF: In a study of 967 Bonafide customers, 71% of women say Bonafide products changed their lives for the better, and 97% say they’d refer the products to a friend suffering from the same problem.
• Resources 1. Chen J, et al. J Sex Med. 2013;10:1575-1584. 2. Agrawal S et al. Menopause. 2023;30(12):1247-1305. 3. Jokar A, et al. IJCBNM. 2016;4(1):69-78. 4. Ilhan G et al. Journal of Menopausal Medicine. 2021;27(1):15. 5. Dweck A, MS MD FACOG, Bernsley D, Sylla S, Komorowski J, MS CNS. A National Survey on Patient Satisfaction and Use Trends with Revaree, a Hyaluronic Acid Suppository, for Vaginal Dryness. The Journal of Sexual Medicine. 2022. 6. Ekin M, et al. Arch Gynecol Obstet. 2011;283:539-543